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Background: Toxoplasma gondii imparts a considerable burden to public health. Human toxoplasmosis can be
life-threatening in immunocompromised individuals, has been associated with psychiatric disorders, and can cause
severe congenital pathologies, spontaneous abortion, or stillbirth. Environmental modes of transmission contributing to
the incidence of human toxoplasmosis are poorly understood. We sought to examine National Health and Nutrition
Examination Survey (NHANES) data for risk factors associated with T. gondii seroprevalence.
Methods: T. gondii serology results reported for Continuous NHANES survey years 1999–2004 and 2009–10 were
examined. To explore associations with toxoplasmosis seropositivity, covariates of interest were selected a priori,
including source and home treatment of tap water. Associations between potential risk factors and evidence of IgG
antibodies against T. gondii were assessed using multivariable logistic regression.
Results: Among 23,030 participants with available T. gondii serology across 8 years of continuous NHANES survey data
(1999–2004; 2009–2010), persons born outside the United States were significantly more likely to be seropositive, and
seropositivity was inversely associated with years spent in the United States. Among US-born participants, participants
with homes on well water (both those who used at-home water treatment devices and those who did not), as well as
participants with public/private company-provided tap water who did not use at-home water treatment devices, were
significantly more likely to be seropositive compared to participants who used home treatment devices on tap water
provided by a private or public water company. A comparative subpopulation analysis revealed age-adjusted
seroprevalence among US-born persons 12-49 yrs old significantly declined to 6.6% (95% CI, 5.2-8.0) (P <0.0001) in
2009–10, compared to previously published reports for NHANES data from 1988–1994 (14.1%) and 1999–2004 (9.0%).
Conclusions: Data suggests that T. gondii infections continue to decline in the United States, but the overall infection
rate remains substantial at nearly 7%. Despite the limitations in the Continuous NHANES cross-sectional survey, the
association between well water use and T. gondii infection warrants further research.
Keywords: Nutrition surveys, Toxoplasma, Drinking water, Water wells, Cross-sectional studiesBackground
Toxoplasma gondii, an obligate intracellular protozoan,
is one of the most widespread zoonotic parasites in the
world. T. gondii infects all warm-blooded animals, but
utilizes domestic and wild cats in the Felidae family as
its definitive host [1-3]. T. gondii infects humans via in-
gestion of undercooked meat containing trophozoites or* Correspondence: wade.tim@epa.gov
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unless otherwise stated.tissue cysts, or through ingestion of sporulated oocysts
found in food, soil, and water recently contaminated
with cat feces [1,4,5]. When oocysts are ingested by an
intermediate host such as humans [6], they migrate in
the host’s body and form permanent cysts in various or-
gans and tissues, but most commonly in the brain [7].
Toxoplasmosis is a lifelong infection that has the poten-
tial to reactivate and cause severe disease and even death
in immunocompromised individuals.
Though primary toxoplasmosis is usually subclinical, se-
quelae can range from mild flu-like symptoms to seizuresl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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the parasite stage ingested, with infections from oocysts
believed to elicit more clinically severe manifestations than
ingestion of tissue cysts [4]. Immunocompromised individ-
uals can experience more severe symptoms, either during
primary infection or following reactivation of latent cysts
[8,9]. Likely attributed to cysts in the brain, psychiatric dis-
orders including mood disorders, personality changes, and
schizophrenia have been associated with chronic T. gondii
infections; however, the underlying etiology is not entirely
clear [10,11]. Of special public health concern, fetuses
can be infected via vertical transmission when a woman
experiences a primary infection during pregnancy. Dis-
seminating tachyzoites colonize placental tissues and
infect the fetus, potentially causing severe injury, still-
birth, or spontaneous abortion. Congenital toxoplasmo-
sis results in the highest burden of disease for human T.
gondii infections [6].
T. gondii has infected an estimated 25-30% of the world’s
population [9]; however prevalence varies across coun-
tries/geographical regions [12]. North America has a lower
prevalence (10-30%) compared to Latin America and trop-
ical regions of Africa, which have a 50-80% prevalence. In
addition to felid presence and density, climatic, anthropo-
genic, economic, social, and cultural factors (e.g. hygienic
practices, dietary habits, cooking methods), as well as
water quality and sanitation coverage all play important
roles in T. gondii environmental persistence, zoonotic
transmission, and prevalence in humans [1]. In the
United States, toxoplasmosis is responsible for one of
the highest direct costs to health care among diseases
partially associated with water-borne transmission [13].
Because recent epidemiological studies could not attri-
bute the majority of T. gondii infections to contaminated
food consumption or soil-related exposures [14,15], other
sources of contamination are likely starting to play a key
role in transmitting T. gondii to humans, especially in the
United States [16]. In the environment, oocysts can resist
freezing and moderately high temperatures to remain vi-
able for years in soil and water [4,17]. Water chemical and
physical treatments, including chlorination and ozone
treatment, are not effective in killing oocysts; however,
oocysts are relatively susceptible to ultraviolet radiation
[18,19]. Although modern municipal water treatment sys-
tems (with filtering, coagulation, flocculation, and settling)
are generally effective at removing oocysts [4], many pop-
ulations do not have access to drinking water that has
undergone this level of treatment. Drinking water is an en-
demic source of T. gondii in Brazil and Guatemala, and
drinking water has been implicated as the source of toxo-
plasmosis outbreaks in several countries [4], including
Panama [20] and Canada [21,22]. Oocysts have not been
directly detected in US drinking water, but assessing envir-
onmental contamination of T. gondii is technically difficult[23]. Researchers have hypothesized that ingesting inad-
equately treated drinking water may be a significant
source for human infections [4,24].
The National Health and Nutrition Examination Survey
(NHANES), within the National Center for Health Statis-
tics of the Centers for Disease Control and Prevention, has
conducted large scale surveys designed to assess changes
over time of the health and nutritional status of adults and
children in the United States. Descriptive epidemiology re-
ports have previously reported T. gondii seroprevalence
trends for past NHANES cohorts (1988–1994 and 1999–
2004) [25-28]. Increased odds of seropositivity were re-
ported with increasing age, poverty, foreign country of
birth, lower level of education, living in crowded condi-
tions, and working in soil-related occupations, which var-
ied by race/ethnicity [25]. To assess the disease burden in
the United States, a comparative subpopulation analysis of
US-born adults aged 12–49 years revealed that T. gondii
seroprevalence declined from 14.1% during the Third
NHANES (1988–1994) to 9.0% during the Continuous
NHANES cycles from 1999–2004 [27].
Because the CDC recently released seroprevalence
data for T. gondii among eligible participants in the
Continuous NHANES 2009–10 cycle, we examined all
available Continuous NHANES data (1999–2004 and
2009–10) to expand on the previous literature and look
for evidence of environmental risk factors associated
with T. gondii seroprevalence among a nationally repre-
sentative population [3].
Methods
Four 2-year cycles of Continuous NHANES data (1999–
2000, 2001–02, 2003–04, and 2009–10) were examined
[3]. Available serum from eligible participants 6-49
yrs old (1999–2004) and ≥6 yrs old (2009–2010) were
tested by the CDC for immunoglobulin G (IgG) anti-
bodies against Toxoplasma gondii by an enzyme im-
munoassay (EIA). A dichotomous seropositivity cut-off
was provided by the CDC (Continuous NHANES 1999–
2004: IgG ≥10 IU/mL = positive; IgG <10 IU/mL = negative;
Continuous NHANES 2009–2010: IgG ≥33 IU/mL = posi-
tive; IgG <33 IU/mL = negative).
Data were collected using a complex survey design;
therefore, seroprevalence estimates were weighted to rep-
resent the total US civilian non-institutionalized popula-
tion, and CDC’s recommended approaches for SAS survey
analysis procedures were followed [3]. All analyses were
conducted using SAS v9.3 (Cary, NC). Using all of the
available NHANES survey data, the authors a priori se-
lected potential covariates of interest to examine associa-
tions with toxoplasmosis seropositivity. Of special interest
were blood biomarkers (using complete blood count re-
sults) to examine clinical severity and exposure to drinking
water, because these factors had not yet been thoroughly
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on serum cotinine level (ng/mL) to delineate light smokers
and second-hand exposure (10-99 ng/mL) from smokers
(≥100 ng/mL). The NHANES variable of ‘household food
security’ was determined using the US Food Security Sur-
vey Module. Affirmative responses were counted from 18
items for households with children and 10 items for
households without children. Categorical data were de-
rived: no affirmative responses = full food security; 1–2 =
marginal food security; 3–5 (without children) or 3–7
(with children) = low food security; 6–10 (without chil-
dren) and 8–18 (with children) = very low food security.
Items included: worried will run out of food, food didn’t
last, couldn’t afford meals, adults cut size or skip meals,
eat less than should, hungry but didn’t eat, adults don’t eat
whole day, and use of emergency foods from food banks,
soup kitchens, or other organizations. For our analyses, we
combined all categories below ‘full food security’ to create
a dichotomous variable.
In the Housing Characteristics (HOQ) questionnaire
participants were asked: “What is the source of tap water
in this home? Is it a private or public water company, a
private or public well, or something else?” and “Are any
of the water treatment devices listed on this card used in
your home?” Treatment devices listed were: Brita® or
other pitcher water filter, ceramic or charcoal filter,
water softener, aerator, and reverse osmosis. In order to
better understand their interaction, the two variables asso-
ciated with tap water were combined into one covariate
with 4 categorical responses (home-treated well water,
home-untreated well water, home-treated water company
and home-untreated water company).
Seroprevalence of IgG antibodies against T. gondii was
assessed with multivariable logistic regression to examine
associations with key demographic characteristics and
potential risk factors associated with seropositivity. Wald
chi-square odds ratio (OR) estimates and 95% confidence
intervals (CI) were ascertained for unadjusted and ad-
justed regression models. Covariates with p values <0.1
were considered for inclusion in multivariable models.
Multivariable models were selected using stepwise back-
wards elimination of covariates with p values > 0.1. Se-
lected models included all covariates with p values < 0.05
as well as any a priori selected demographic characteris-
tics that confounded observed associations between inde-
pendent variables and the outcome.
Results
Across the 8 years of Continuous NHANES data for which
T. gondii seroprevalence was examined (1999–2000, 2001–
02, 2003–04, and 2009–10), T. gondii serology results were
available for 23,030 participants (Table 1). Approximately
5,300 participants 6-49 yrs old were included in each
of the first 3 Continuous NHANES cycles (1999–2000,2001–02, and 2003–04). For the more recent cycle (2009–
10), the eligible population was expanded to all partici-
pants ≥6 yrs old; therefore, this cycle had a larger subgroup
of over 7,000 participants. T. gondii seroprevalence was
also significantly different across key demographic vari-
ables, including age, gender, race/ethnicity, and poverty
index (Table 1). Controlling for age, there was a statisti-
cally significant difference in overall T. gondii seropreva-
lence among the survey years, (P <0.0001) with adjusted
odds of seropositivity in both 2001–02 and 2009–10 cycles
significantly lower compared to the 1999–2000 cycle (data
not shown).
Risk factor associations were first assessed for all 23,030
participants using multivariable logistic regression (Table 2).
Increasing age was significantly associated with T. gondii
seropositivity, and men were more likely to be seropositive
than women (adjusted OR [AOR] = 1.2; 95% CI, 1.1-1.4).
Compared to non-Hispanic Whites, Mexican Americans
were less likely to be seropositive (AOR = 0.5; 95% CI, 0.4-
0.7), while non-Hispanic Blacks and other Hispanics
had significantly elevated adjusted odds of seropreva-
lence (AOR = 1.3; 95% CI, 1.04-1.6 and AOR = 1.6; 95%
CI, 1.3-2.1; respectively). Compared to full food security,
having marginally secure or insecure household food was
associated with higher odds of seropositivity (AOR= 1.3;
95% CI, 1.1-1.5). Smokers had higher odds of seropositivity
compared to non-smokers (AOR = 1.2; 95% CI, 1.03-1.5).
In addition, the largest effect was observed for country of
birth origin. Compared to participants born in the United
States, participants born in Mexico had significantly higher
odds of seropositivity (AOR = 6.3; 95% CI, 4.7-8.4), as did
participants born in a foreign country other than Mexico
(AOR= 3.7; 95% CI, 3.0-4.6). In examining health corre-
lates, an inverse association was observed with partici-
pants’ self-reported general health condition – the worse
the perceived health condition, the higher odds of sero-
positivity (Table 2). Participants who reported taking treat-
ment for anemia in the past 3 months were more likely
to have antibodies against T. gondii (AOR = 1.4; 95% CI,
1.01-2.0). In unadjusted comparisons there was a signifi-
cant association between seropositivity and eosinophilia,
but the effect diminished in the multivariable model.
Associations between T. gondii seroprevalence, tap water
source, and using home water treatment devices were ob-
served (Table 2). Compared to participants using home-
treated company water, participants with home-untreated
well water had a 1.5 times higher adjusted odds (95% CI,
1.02-2.2) of T. gondii seropositivity. Because there was a
high correlation between seropositivity and country of ori-
gin, we theorized that if seropositive participants born out-
side the United States were more likely to be infected
while living abroad (where risk of T. gondii infection is
higher), then their source of drinking water once living in
the United States would not have the same association
Table 1 Toxoplasma gondii seroprevalencea by demographic characteristics for participants ≥6 years old; NHANES
1999–2004, 2009-10b
Variable N Prevalence (%)c 95% CL P
Overall 23030 2642 (11.7) 10.8,12.6
Continuous NHANES survey year 0.0116
1999-2000 5089 602 (13.3) 11.6,15.1
2001-2002 5751 527 (9.3) 7.1,11.4
2003-2004 5120 434 (10.8) 8.6,13.0
2009-2010 7070 1079 (13.2) 11.9,14.4
Age group (years) <0.0001
6-12 4274 155 (3.5) 2.5,4.4
13-17 4693 279 (4.6) 3.7,5.6
18-28 4810 488 (9.2) 7.7,10.7
29-43 4799 757 (14.0) 12.4,15.6
44-80 4450 963 (17.7) 16.0,19.4
Gender 0.0133
Male 11239 1402 (12.6) 11.4,13.8
Female 11791 1240 (10.8) 9.8,11.9
Race/ethnicity <0.0001
Non-Hispanic White 8546 854 (9.9) 8.8,11.0
Non-Hispanic Black 5535 566 (12.6) 10.7,14.5
Mexican American 6441 749 (13.6) 11.7,15.5
Other Hispanic 1490 366 (24.8) 19.7,30.0
Other, incl multi-racial 1018 107 (12.9) 10.1,15.7
Poverty indexd,e <0.0001
Below 5807 744 (14.3) 12.5,16.1
At or above 15454 1621 (10.9) 9.9,11.8
Country of origind <0.0001
United States 18358 1401 (8.9) 7.9,9.9
Mexico 2661 614 (24.1) 21.4,26.7
Elsewhere 2005 627 (29.2) 25.7,32.7
aFor Continuous NHANES 1999–2004: IgG ≥10 IU = positive; IgG <10 IU = negative. For Continuous NHANES 2009–2010: IgG ≥33 IU/mL = positive; IgG <33 IU/mL =
negative. bT. gondii serology performed only among participants ages 6–49 for 1999–2004 data. cAll prevalence estimates were weighted. dCovariate has some
missing data. eFamily income-to-poverty ratio (FIPR) categorized as 0.00–0.99 = below poverty; 1.00 and above = at or above poverty.
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next examined the association of drinking water and IgG
antibodies against T. gondii separately among US-born
and foreign-born participants (Table 3).
US-born participants
The final multivariable model included NHANES survey
year, age, gender, household food security, race/ethnicity,
smoking status, general health condition and source/treat-
ment of tap water (Table 3). Mexican Americans and other
Hispanics were less likely to be seropositive compared to
non-Hispanic Whites (AOR= 0.5; 95% CI, 0.4-0.7 and
AOR= 0.5; 95% CI, 0.3-0.98; respectively). Smokers had a
higher odds of seropositivity compared to non-smokers
(AOR = 1.3; 95% CI, 1.1-1.6), and participants who reportedfair or poor health were more likely to be seropositive
(AOR = 1.5; 95% CI, 1.1-1.9) than participants who re-
ported very good or good health, when compared to
participants who reported excellent health. Participants
with homes on well water (both those who used at-
home water treatment devices on the well water [AOR =
1.6; 95% CI, 1.2-2.1] and those who did not [AOR = 1.7;
95% CI, 1.1-2.4]), as well as participants using home-
untreated company tap water (AOR = 1.2; 95% CI, 1.01.-
1.5) had significantly higher odds of seropositivity
compared to participants using home-treated tap water
provided by a private or public water company.
To expand on the comparative subpopulation analysis
previously reported by Jones et al., among US-born persons
12–49 years old, T. gondii age-adjusted seroprevalence
Table 2 Risk factors associated with antibodiesa against Toxoplasma gondii among participants ≥6 years old; NHANES
1999–2004, 2009-10b
Variable N IgG positivec Unadjusted ORd Adjusted ORd
n (%) (95% CI) (95% CI)
Survey year
1999-2000 5089 602 (13.3) Ref Ref
2001-2002 5751 527 (9.3) 0.7 (0.5-0.9)e 0.7 (0.5-0.9)
2003-2004 5120 434 (10.8) 0.8 (0.6-1.0) 0.8 (0.6-1.1)
2009-2010 7070 1079 (13.2) 1.0 (0.8-1.2) 0.6 (0.5-0.7)
Age
Continuous (years) 23030 2642 (11.7) 1.03 (1.03-1.03) 1.03 (1.03-1.04)
Age group (years)
6-12 4274 155 (3.5) Ref –
13-17 4693 279 (4.6) 1.4 (1.03-1.8) –
18-28 4810 488 (9.2) 2.8 (2.3-3.5) –
29-43 4799 757 (14.0) 4.5 (3.6-5.8) –
≥44 4450 963 (17.7) 6.0 (4.5-8.0) –
Gender
Female 11791 1240 (10.8) Ref Ref
Male 11239 1402 (12.6) 1.2 (1.04-1.4) 1.2 (1.1-1.4)
Race/Ethnicity
Non-Hispanic White 8546 854 (9.9) Ref Ref
Non-Hispanic Black 5535 566 (12.6) 1.3 (1.1-1.6) 1.3 (1.04-1.6)
Mexican American 6441 749 (13.6) 1.4 (1.2-1.7) 0.5 (0.4-0.7)
Other Hispanic 1490 366 (24.8) 3.0 (2.3-4.0) 1.6 (1.3-2.1)
Other, incl. multiracial 1018 107 (12.9) 1.3 (1.02-1.8) 0.7 (0.5-1.0)
Household food securityf
Full food security 15104 1593 (10.9) Ref Ref
Marginally secure or insecure 7212 973 (14.5) 1.4 (1.2-1.6) 1.3 (1.1-1.5)
Smoking statusf,g
Non-smoker 18438 1977 (11.0) Ref Ref
Light smoker/moderate second-hand exposure 1387 194 (13.0) 1.2 (1.0-1.5) 1.1 (0.9-1.4)
Smoker 3045 447 (14.1) 1.3 (1.1-1.6) 1.2 (1.03-1.5)
Country of originf
United States 18358 1401 (8.9) Ref Ref
Mexico 2661 614 (24.1) 3.2 (2.7-3.9) 6.3 (4.7-8.4)
Elsewhere 2005 627 (29.2) 4.2 (3.4-5.2) 3.7 (3.0-4.6)
Source and home treatmenth of tap waterf
Home-treated private/public water company 4129 420 (9.9) Ref Ref
Home-untreated private/public water company 16089 1855 (12.1) 1.2 (1.1-1.4) 1.2 (1.003-1.4)
Home-treated well water 1056 143 (12.7) 1.3 (1.05-1.7) 1.4 (1.1-1.8)
Home-untreated well water 1107 143 (12.3) 1.3 (0.9-1.8) 1.5 (1.02-2.2)
General health conditionf
Excellent 6341 477 (8.5) Ref Ref
Very good 6306 588 (9.8) 1.2 (1.0-1.4) 1.1 (0.9-1.3)
Good 7090 920 (13.3) 1.7 (1.4-1.9) 1.2 (1.04-1.4)
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Table 2 Risk factors associated with antibodiesa against Toxoplasma gondii among participants ≥6 years old; NHANES
1999–2004, 2009-10b (Continued)
Fair 2835 552 (19.2) 2.6 (2.2-2.9) 1.5 (1.3-1.8)
Poor 447 103 (25.1) 3.6 (2.6-5.0) 1.9 (1.4-2.7)
Took treatment for anemia in past 3 monthsf
No 22397 2526 (11.5) Ref Ref
Yes 625 113 (18.5) 1.7 (1.3-2.3) 1.4 (1.01-2.0)
Blood eosinophils numberf
Continuous (1000 cells/uL) 22940 2629 (11.7) 1.4 (1.02-1.9) 1.3 (1.0-1.7)
aFor Continuous NHANES 1999–2004: IgG ≥10 IU = positive; IgG <10 IU = negative. For Continuous NHANES 2009–2010: IgG ≥33 IU/mL =positive; IgG <33 IU/mL = negative.
bT. gondii serology performed only among participants ages 6–49 for 1999–2004 data. cAll prevalence estimates were weighted. dWald Chi-square logistic regression used.
eBolded font denotes statistically significant data (P< 0.05). fCovariate has some missing data. gBased on serum cotinine level (ng/mL); nonsmoker <10, light smoker/second-
hand exposure 10–99, smoker ≥100. hTypes of home water treatment devices included: Brita® or other pitcher water filter, ceramic or charcoal filter, water softener, aerator,
reverse osmosis.
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the 2009–10 NHANES cycle, compared to 14.1% (95% CL,
12.7-15.5) during the Third NHANES (1988–1994) and
9.0% (95% CL, 7.5-10.4) during the Continuous NHANES
1999–2004 [27] (data not shown).Foreign-born participants
After adjusting for residential environment, the final
multivariable model included NHANES survey year,
age, gender, household food security, race/ethnicity,
percentage of lifetime lived in the United States, smok-
ing status, general health condition, source of tap water,
anemia treatment, and eosinophilia (Table 3). In con-
trast to the US-born participants, among foreign-born
participants, a higher T. gondii seroprevalence was ob-
served among Hispanics other than Mexican American
(AOR = 2.3; 95% CI, 1.7-3.0) and non-Hispanic Blacks
(AOR = 1.9; 95% CI, 1.3-2.9). A lower seroprevalence
was observed among “other” races, including multiracial
(AOR = 0.5; 95% CI, 0.4-0.8). When considering the
percentage of one’s lifetime spent living in the United
States, a clear trend was observed, where the lower the
percentage of lifetime, the higher the likelihood of T.
gondii seropositivity (AOR = 2.5; 95% CI, 1.9-3.4 for
living ≤40% of lifetime compared to ≥76%). In regards
to health status, as observed in US-born participants,
foreign-born participants who reported a fair or poor
general health condition were more likely to be sero-
positive (AOR = 1.6; 95% CI, 1.2-2.2). In addition, par-
ticipants with a blood eosinophil count above the
normal range (≥3500 cells/uL) and participants who re-
ported taking treatment for anemia in the past 3 months
were significantly more likely to be seropositive (AOR =
1.5; 95% CI, 1.2-1.8 and AOR = 1.8; 95% CI, 1.1-3.0; re-
spectively). Source of tap water and using home water
treatment devices were not associated with T. gondii
seroprevalence among foreign-born participants.Discussion
We observed statistically significant increased odds of T.
gondii seropositivity among US-born NHANES partici-
pants whose tap water source was well water (both home
treated and untreated), as well as home-untreated com-
pany water, compared to participants who used home-
treated water from a private or public water company.
The absence of significant associations between tap water
source/treatment and T. gondii seropositivity among those
not born in the United States provides additional evidence
that drinking water may be an important source of toxo-
plasmosis in the United States.
Although T. gondii oocysts are resistant to chlorine and
other types of disinfection [4], because of their relatively
large size (10–12 μm), they should be removed by standard
municipal treatment consisting of coagulation, floccula-
tion, and settling prior to filtration [29]. While outbreaks
of T. gondii have only been attributed to municipal waters
using unfiltered water systems (Brazil and Canada), out-
breaks could also occur following a water treatment break-
down or operation error [30]. In addition,T. gondii oocysts
have been found to be widespread in wells located on
farms [31] and can survive for long periods in soil and
water [24]. A study conducted among farms in Poland re-
ported an association between well water consumption
and toxoplasmosis IgG seropositivity [31]. Not only was a
positive correlation observed between drinking well water
and T. gondii seropositivity among persons living on the
farms (P < 0.05), but T. gondii DNA was found significantly
more frequently in water samples collected from windlass-
operated wells (37.5%) than water from deep wells with a
pump (6.2%) and from water supply systems (0%). Well
water, especially private or from a small shared source, is
probably much less likely to be filtered adequately to re-
move T. gondii oocysts. Although we lacked much neces-
sary detail to draw definitive conclusions, our results are
consistent with an association between well water and T.
gondii infection.
Table 3 Risk factors associated with antibodiesa against Toxoplasma gondii among participants ≥6 years old by














n (%) (95% CI) (95% CI) n (%) (95% CI) (95% CI)
Survey year
1999-2000 4010 320 (9.7) Ref Ref 1078 282 (32.3) Ref Ref
2001-2002 4699 276 (7.4) 0.7 (0.5-1.1) 0.7 (0.5-1.1) 1052 251 (21.8) 0.6 (0.4-0.9)e 0.6 (0.4-0.9)
2003-2004 4248 231 (7.9) 0.8 (0.5-1.2) 0.8 (0.5-1.2) 872 203 (28.0) 0.8 (0.5-1.3) 0.8 (0.6-1.1)
2009-2010 5401 574 (10.3) 1.1 (0.8-1.4) 0.6 (0.4-0.7) 1664 505 (27.6) 0.8 (0.6-1.2) 0.7 (0.5-0.9)
Age
Continuous (years) 18358 1401 (8.9) 1.03 (1.03-1.04) 1.04 (1.03-1.04) 4666 1241 (27.5) 1.02 (1.01-1.02) 1.03 (1.02-1.04)
Gender
Female 9481 652 (8.2) Ref Ref 2307 588 (26.7) Ref Ref
Male 8877 749 (9.6) 1.2 (1.002-1.4) 1.2 (1.05-1.5) 2359 653 (28.2) 1.1 (0.9-1.3) 1.1 (0.9-1.4)
Race/Ethnicity
Non-Hispanic White 8131 756 (9.2) Ref Ref 415 98 (22.8) Ref Ref
Non-Hispanic Black 5104 419 (10.0) 1.1 (0.9-1.4) 1.2 (0.9-1.5) 430 147 (38.3) 2.1 (1.4-3.1) 1.9 (1.3-2.9)
Mexican American 3773 140 (3.8) 0.4 (0.3-0.5) 0.5 (0.4-0.7) 2666 609 (23.9) 1.1 (0.8-1.4) 0.9 (0.7-1.2)
Other Hispanic 727 37 (4.3) 0.4 (0.3-0.8) 0.5 (0.3-0.98) 760 329 (44.1) 2.7 (2.0-3.6) 2.3 (1.7-3.0)
Other, incl. multiracial 623 49 (10.8) 1.2 (0.8-1.8) 1.5 (1.0-2.3) 395 59 (15.4) 0.6 (0.4-0.9) 0.5 (0.4-0.8)
Household food securityf
Full food security 12523 942 (8.7) Ref Ref 2581 651 (25.0) Ref Ref
Marginally secure or insecure 5246 414 (9.3) 1.1 (0.9-1.3) 1.3 (1.01-1.6) 1962 559 (33.1) 1.5 (1.2-1.8) 1.2 (1.0-1.5)
Renting vs. owning home
Owned/being bought 10861 877 (9.3) Ref – 1956 459 (23.7) Ref Ref
Rented/other arrangement 7332 498 (8.0) 0.9 (0.7-1.0) – 2666 769 (30.7) 1.4 (1.2-1.7) 1.3 (1.1-1.6)
Smoking statusf,g
Non-smoker 14427 933 (7.7) Ref Ref 4005 1044 (27.3) Ref –
Light smoker/2nd hand exposure 1082 105 (9.3) 1.2 (0.9-1.6) 1.2 (0.9-1.6) 305 89 (29.4) 1.1 (0.8-1.6) –
Smoker 2717 351 (12.9) 1.8 (1.5-2.1) 1.3 (1.1-1.6) 329 96 (26.7) 1.0 (0.7-1.4) –
Water sourcef
Home-treatedh water company 3267 194 (6.9) Ref Ref 861 226 (26.2) Ref Ref
Home-untreated water
company
12608 922 (8.7) 1.3 (1.05-1.6) 1.2 (1.01-1.5) 3476 933 (28.3) 1.1 (0.9-1.4) 1.0 (0.7-1.3)
Home-treated well water 990 131 (12.4) 1.9 (1.4-2.6) 1.6 (1.2-2.1) 66 12 (19.4) 0.7 (0.3-1.8) 0.5 (0.2-1.0)
Home-untreated well water 1016 119 (12.0) 1.8 (1.3-2.7) 1.7 (1.1-2.4) 91 24 (19.8) 0.7 (0.4-1.3) 0.8 (0.4-1.4)
General health conditionf
Excellent 5456 293 (6.8) Ref Ref 885 184 (21.8) Ref Ref
Very good 5372 365 (8.0) 1.2 (1.0-1.5) 1.0 (0.8-1.3) 932 223 (24.2) 1.2 (0.9-1.5) 1.1 (0.8-1.5)
Good 5360 450 (9.8) 1.5 (1.2-1.9) 1.1 (0.9-1.4) 1728 470 (28.5) 1.4 (1.1-1.8) 1.2 (0.9-1.6)
Fair/poor 2164 292 (14.9) 2.4 (1.9-3.0) 1.5 (1.1-1.9) 1116 363 (36.1) 2.0 (1.6-2.6) 1.6 (1.2-2.2)
Took treatment for anemia in past
3 mosf
No 17859 1334 (8.7) Ref – 4533 1192 (27.3) Ref Ref
Yes 493 65 (14.8) 1.8 (1.3-2.6) – 131 48 (40.4) 1.8 (1.1-3.1) 1.8 (1.1-3.0)
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Table 3 Risk factors associated with antibodiesa against Toxoplasma gondii among participants ≥6 years old by
country of birth; NHANES 1999–2004, 2009-10b (Continued)
Blood eosinophils number
(1000 cells/uL)f
Normal (<0.35) 15960 1239 (8.9) Ref – 4061 1040 (26.4) Ref Ref
Above normal (≥0.35) 2441 158 (8.6) 1.0 (0.8-1.2) – 573 192 (35.1) 1.5 (1.2-1.9) 1.5 (1.2-1.8)
Percentage of lifetime lived in USf
≥0.76 – – – – 1147 206 (18.3) Ref Ref
0.61-0.75 – – – – 1044 295 (29.7) 1.9 (1.4-2.5) 1.9 (1.4-2.5)
0.41-0.60 – – – – 1149 337 (29.5) 1.9 (1.4-2.4) 2.2 (1.6-2.8)
≤0.40 – – – – 1175 364 (32.5) 2.2 (1.7-2.7) 2.5 (1.9-3.4)
aFor Continuous NHANES 1999–2004: IgG ≥10 IU = positive; IgG <10 IU = negative. For Continuous NHANES 2009–2010: IgG ≥33 IU/mL =positive; IgG <33 IU/mL = negative.
bT. gondii serology performed only among participants ages 6–49 for Continuous NHANES 1999–2004 data. cAll prevalence estimates were weighted. dWald Chi-square
logistic regression used. eBolded font denotes statistically significant data (P < 0.05). fCovariate has some missing data. gBased on serum cotinine level (ng/mL);
nonsmoker <10, light smoker/second-hand exposure 10–99, smoker ≥100. hTypes of home water treatment devices included: Brita® or other pitcher water filter,
ceramic or charcoal filter, water softener, aerator, reverse osmosis.
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http://www.biomedcentral.com/1471-2458/14/711Because the information collected on the type of water
treatment was limited, it is difficult to interpret the ef-
fect of additional home treatment. Some treatments in-
cluded in the question such as water softeners, would
not have any effect on T. gondii oocysts, and even most
water filters are simply designed to reduce taste and
odor or reduce some chemicals such as lead and chlor-
ine. Because oocysts are 10–12 μm in size [32], some
standard Brita® filters, such as faucet (0.5 micron) and
pitcher (1 micron) filters are expected to effectively re-
move oocysts, but other filters are only designed for
taste and odor improvement and would have no effect.
Moreover, the effectiveness of home treatments is im-
pacted by maintenance and upkeep of the filter system.
The use of additional treatment may also signal in-
creased awareness and concern of water contamination
and such participants may be more careful about general
hygiene and the water they choose to drink.
Our analyses confirmed previous reports that those
born outside the United States had higher odds for T.
gondii seropositivity, supporting the evidence that other
countries have a higher endemicity of human toxoplas-
mosis. We further demonstrated that the percentage of
one’s lifetime lived in the United States was inversely as-
sociated with T. gondii infection. Due to the NHANES
classification of country of birth origin, we were unable
to conduct meaningful analyses of which countries rep-
resent a higher risk of T. gondii infection. Seropreva-
lence varied among different race/ethnicity groups when
stratified by country of origin, which is consistent with
previous reports [25,28]. Stratification by country of ori-
gin also suggested blood eosinophils above the normal
range and reported treatment for anemia in the past
3 months were associated with T. gondii seropositivity
for foreign-born participants, but not for US-born par-
ticipants. While these factors may simply be correlates
of infection and not clinically associated with T. gondiiinfections, molecular and experimental infection studies
have discovered that T. gondii genotypes vary in viru-
lence, and these genetic lineages have evolved in differ-
ent regions of the world [1]. Highly clonal genotypes II
and III, the primary lineages in North America and
Europe are considered to be avirulent in immunocompe-
tent persons. In contrast, atypical genotypes resulting from
frequent genetic exchanges and genetic drift have been as-
sociated with greater clinical severity. High genetic diver-
sity among T. gondii isolates has been found in South
America, Africa, and Asia. Because the clinical symptoms
of anemia and inflammation were observed only among
seropositive foreign-born NHANES participants, perhaps
those born outside the United States acquired toxoplas-
mosis from more virulent strains. Following ingestion, T.
gondii parasites invade the gastrointestinal wall, disse-
minate, and elicit a strong immune response that triggers
significant ancillary pathologies; anemia and eosinophilia
have been reported in clinically severe cases of toxoplas-
mosis [33-37].
While the Continuous NHANES collects a wealth of in-
formation for a national, representative sample of the
United States population, we do recognize its limitations.
The cross-sectional survey design prevents us from infer-
ring causality. In addition, combining datasets across mul-
tiple survey years can be a limitation, depending on the
covariates of interest. Questions and medical exams are
not constant across the survey years: response options
change, questions/medical tests are added, and questions/
medical tests are dropped. In addition, several question-
naires and medical exams are administered to only sub-
groups (e.g. adults ≥20 years old). Because previous papers
of T. gondii seroprevalence among NHANES participants
analyzed subgroups that had additional NHANES data,
e.g. education level and occupation among adults ≥20 years
old [26], our goal was to maintain the largest cohort as
possible for consistency and increased power.
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http://www.biomedcentral.com/1471-2458/14/711Unfortunately, there was very limited data for other risk
factors of interest, including the presence of T. gondii in
drinking water sources, occupations with soil and water
exposure, mental health status (e.g. depression and schizo-
phrenia), and overall dietary behaviors (e.g. eating under-
cooked meat). In addition, as a health and nutrition survey,
NHANES does not collect data regarding exposure to rec-
reational waters, a key interest in environmental T. gondii
transmission. Antibodies against T. gondii have been found
in several species of marine mammals off of both US
coastlines [23], suggesting that freshwater runoff is con-
taminating sea water [38]. This raises the question about
the risk to humans from accidentally swallowing contami-
nated water during recreational exposure to rivers, lakes,
and ocean waters [4]. Despite these limitations, this study
provides risk factor data that can inform future envir-
onmental assessments and prospective human studies
to better link cause and effect for water-associated
toxoplasmosis.
Conclusions
Our findings are consistent with national trends observed
in previous studies of T. gondii seroprevalence among
NHANES participants. Seroprevalence is declining in the
United States, with only 6.6% of the US-born population
12–49 years of age having serological evidence of T. gondii
infection during 2009–10, compared to 9.0% during 1999–
2004 and 14.1% during 1988–1994. We similarly observed
differences in seropositivity by country of birth origin and
race/ethnicity. There was also a significant association with
less than excellent self-reported general health condition
and seropositivity. Furthermore, this is the first paper to
report associations between tap water source and T. gondii
among US-born residents; although, a casual association
cannot be demonstrated due to the cross-sectional design
of NHANES. In addition, because standard T. gondii sero-
logical assays cannot differentiate environmentally-acquired
oocyst infections from foodborne tissue cyst infections, re-
cently developed oocyst antigen-specific assays, including
the enzyme-linked immunoassay developed by Hill et al.
[39], are valuable tools to more accurately assess the dis-
ease burden of environmental exposures to T. gondii. In
addition, further investigations are warranted to examine
how well water may be contaminated with oocysts, what
role well systems may play in maintaining and spreading
oocysts, and which home water treatment devices are ef-
fective in eliminating oocysts from tap water.
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